Nurix Therapeutics to Present at the Needham & Company 18th Annual Healthcare Conference

On April 4, 2019 Nurix Therapeutics, Inc., a private company discovering drugs that harness the body’s natural process to control protein levels, reported that Arthur Sands, M.D., Ph.D., chief executive officer, reported that it will present at the Needham & Company 18th Annual Healthcare Conference to be held on April 9-10, 2019 in New York City (Press release, Nurix Therapeutics, APR 4, 2019, View Source [SID1234535006]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:
Presentation Title: Nurix Corporate Overview
Date: Tuesday, April 9th, 2019
Time: 2:10 – 2:30 p.m. EDT